TY  - GEN
AU  - Gay,Francesca
AU  - Rajkumar,S Vincent
AU  - Coleman,Morton
AU  - Kumar,Shaji
AU  - Mark,Tomer
AU  - Dispenzieri,Angela
AU  - Pearse,Roger
AU  - Gertz,Morie A
AU  - Leonard,John
AU  - Lacy,Martha Q
AU  - Chen-Kiang,Selina
AU  - Roy,Vivek
AU  - Jayabalan,David S
AU  - Lust,John A
AU  - Witzig,Thomas E
AU  - Fonseca,Rafael
AU  - Kyle,Robert A
AU  - Greipp,Philip R
AU  - Stewart,A Keith
AU  - Niesvizky,Ruben
TI  - Clarithromycin (Biaxin)-lenalidomide-low-dose dexamethasone (BiRd) versus lenalidomide-low-dose dexamethasone (Rd) for newly diagnosed myeloma
SN  - 1096-8652
PY  - 2010///1001
KW  - Adult
KW  - Aged
KW  - Aged, 80 and over
KW  - Antineoplastic Combined Chemotherapy Protocols
KW  - administration & dosage
KW  - Case-Control Studies
KW  - Clarithromycin
KW  - Dexamethasone
KW  - Disease-Free Survival
KW  - Double-Blind Method
KW  - Female
KW  - Humans
KW  - Lenalidomide
KW  - Male
KW  - Middle Aged
KW  - Multiple Myeloma
KW  - mortality
KW  - Survival Rate
KW  - Thalidomide
KW  - Thrombocytopenia
KW  - chemically induced
N1  - Publication Type: Clinical Trial; Comparative Study; Journal Article; Multicenter Study; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1002/ajh.21777
ER  -